|
Market Closed -
NYSE
16:00:02 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 52.41 USD | +0.87% |
|
+5.84% | +6.87% |
| 08-21 | WINNERS & LOSERS: Hunting falls on outlook cut; miners rise | AN |
| 08-20 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,119B | |||||
| 651B | - | - | - | ||
| 468B | |||||
| 374B | |||||
| 302B |
- Stock Market
- Stocks
- GSK Stock
- GSK Stock
- Charts GSK plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
